These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14415046)

  • 1. LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    AMA Arch Gen Psychiatry; 1960 Apr; 2():390-407. PubMed ID: 14415046
    [No Abstract]   [Full Text] [Related]  

  • 2. LSD and JB 318: a comparison of two hallucinogens. III. Qualatative analysis and summary of findings.
    LEBOVITS BZ; VISOTSKY HM; OSTEFELD AM
    Arch Gen Psychiatry; 1962 Jul; 7():39-45. PubMed ID: 14463342
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysergic acid diethylamide (LSD) and JB 318: a comparison of two hallucinogens. II. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    Arch Gen Psychiatry; 1960 Aug; 3():176-87. PubMed ID: 14415047
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of LSD 25 and JB 318 on tests of visual and perceptual functions in man.
    OSTFELD AM
    Fed Proc; 1961 Dec; 20():876-84. PubMed ID: 14482599
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the reactions induced by psilocybin and LSD-25 in man.
    ISBELL H
    Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of psilocin with psilocybin, mescaline and LSD-25.
    WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1962; 3():219-23. PubMed ID: 14007905
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of lysergic acid diethylamide and bufotenine on performance of trained rats.
    MAHLER DJ; HUMOLLER FL
    Proc Soc Exp Biol Med; 1959; 102():697-701. PubMed ID: 14419947
    [No Abstract]   [Full Text] [Related]  

  • 10. JB 329 degrees--a new spychotomimetic, its antagonism by tetrahydroaminacrin and its comparison with LSD, mescaline and sernyl.
    GERSHON S; OLARIU J
    J Neuropsychiatr; 1960; 1():283-92. PubMed ID: 13827606
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of 2,3-dihydro-lysergic acid diethylamide with LSD-25.
    Gorodetzky CW; Isbell H
    Psychopharmacologia; 1964 Sep; 6(3):229-33. PubMed ID: 5319153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern treatments in psychiatry. Hallucinogens: psychosis induced by LSD].
    JOST F; GEERTZ VW
    Folia Clin Int (Barc); 1961 Sep; 11():440-5 contd. PubMed ID: 14452572
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical observations of simultaneous hallucinogen administration in identical twins.
    WILKENS B; MALITZ S; ESECOVER H
    Am J Psychiatry; 1962 Mar; 118():815-8. PubMed ID: 14007020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z; Podvalová I; Vojtĕchovský M
    Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.
    Geyer MA; Petersen LR; Rose GJ; Horwitt DD; Light RK; Adams LM; Zook JA; Hawkins RL; Mandell AJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):837-47. PubMed ID: 731434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects.
    Liester MB
    Curr Drug Abuse Rev; 2014; 7(3):146-56. PubMed ID: 25563445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A characteristic effect of hallucinogens on investigatory responding in rats.
    Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
    Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
    Nichols DE
    J Theor Biol; 1976 Jun; 59(1):167-77. PubMed ID: 7711
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of lysergic acid diethylamide: case reports and review of the treatment of intoxication.
    Blaho K; Merigian K; Winbery S; Geraci SA; Smartt C
    Am J Ther; 1997; 4(5-6):211-21. PubMed ID: 10423613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.